Editorial outlines expectations for ethical use of GenAI in scholarly publishing, emphasizing integrity and accountability.
Generative artificial intelligence (GenAI) tools are increasingly used in scholarly writing and publishing. While these technologies offer potential benefits in language refinement and workflow support, they also raise important ethical, legal, and procedural concerns. This editorial outlines the expectations of the Ibnosina Journal of Medicine and Biomedical Sciences (IJMBS) regarding the responsible use of GenAI tools. Drawing on international guidance from major editorial and ethics bodies, it emphasizes principles of human accountability, transparent disclosure, and scientific integrity. Specific guidance is provided for authors, peer reviewers, and editors. IJMBS affirms its commitment to upholding best practices and preserving the credibility of the scientific record in the era of artificial intelligence.
No takes yet. Share an insight, caveat, or question.
Beshyah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: